Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
NASA releases new ‘Earthset’ and eclipse images taken during historic flyby of the moon - 2Apollo vs. Artemis: What to know about NASA's return to the moon
- 36 Shades Brands For Seniors
- 4Hundreds of Intact Dinosaur Eggs Emerge From 72-Million-Year Time Capsule
- 5German finance minister sees advantages of smartphones in schools
- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Hubble Space Telescope spies dusty debris from two cosmic collisions
- America's Confided in Fridge in 2024
- Don't miss Jupiter shining close to the waning gibbous moon on Dec. 7
- French high-speed train slams into truck, killing TGV driver
- Nigeria police charge Joshua driver with dangerous driving over fatal crash
- Russia earning billions from Hormuz blockade, German trade body says
- Russia Creates New Military Branch Dedicated To Drone Warfare
